124. Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the EPIC Study

BACKGROUND: PLZ is a next-generation aminoglycoside (AG) that is structurally protected from common AG-modifying enzymes (AMEs) in Enterobacteriaceae and with in vitro activity against multidrug-resistant Enterobacteriaceae, including ESBL-producing, AG-resistant, and carbapenem-resistant isolates....

Descripción completa

Detalles Bibliográficos
Autores principales: Keepers, Tiffany R, Cebrik, Deborah S, Cloutier, Daniel J, Komirenko, Allison, Connolly, Lynn, Krause, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253087/
http://dx.doi.org/10.1093/ofid/ofy209.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253087/
http://dx.doi.org/10.1093/ofid/ofy209.014

Ejemplares similares